At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
N95 mask +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A New Fully-reusable, Affordable, Comfortable Mask Design With Superior Filtration and Fit for Use During Respirator Shortages and Pandemics
In Brief
A clinical study evaluating N95 mask, Nordell single E-100 layer mask, and 1 other intervention for Covid19 and 2 related conditions. Completed, enrolled 41 participants across 1 site.
Detailed Summary
This study will test the filtration, air leak, and breathability of a newly designed fully washable mask developed by Dr. Nordell with the Mayo Clinic. This mask is theorized to be a superior alternative to other respirators currently used when one-time-use N95 masks are unavailable.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, Tuberculosis, Respiratory Viral Infection
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartApr 2021
Primary CompletionOct 2022
TodayJul 2026
First PostedApr 1, 2021
Enrollment StartApr 9, 2021
Primary CompletionOct 27, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.3 years ago
Interventions
N95 maskdevice
Standard 1870 N95 one time use mask
Nordell single E-100 layer maskdevice
Nordell mask design using one layer of E-100 fabric plus cotton fabric overlay
Nordell double E-100 layer maskdevice
Nordell mask design using two layers of E-100 fabric